BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35135603)

  • 1. Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.
    Barbieri F; Bosio AG; Pattarozzi A; Tonelli M; Bajetto A; Verduci I; Cianci F; Cannavale G; Palloni LMG; Francesconi V; Thellung S; Fiaschi P; Mazzetti S; Schenone S; Balboni B; Girotto S; Malatesta P; Daga A; Zona G; Mazzanti M; Florio T
    J Exp Clin Cancer Res; 2022 Feb; 41(1):53. PubMed ID: 35135603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability.
    Barbieri F; Würth R; Pattarozzi A; Verduci I; Mazzola C; Cattaneo MG; Tonelli M; Solari A; Bajetto A; Daga A; Vicentini LM; Mazzanti M; Florio T
    Front Pharmacol; 2018; 9():899. PubMed ID: 30186163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.
    Gritti M; Würth R; Angelini M; Barbieri F; Peretti M; Pizzi E; Pattarozzi A; Carra E; Sirito R; Daga A; Curmi PM; Mazzanti M; Florio T
    Oncotarget; 2014 Nov; 5(22):11252-68. PubMed ID: 25361004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity.
    Barbieri F; Verduci I; Carlini V; Zona G; Pagano A; Mazzanti M; Florio T
    Front Oncol; 2019; 9():135. PubMed ID: 30918838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLIC1 regulation of cancer stem cells in glioblastoma.
    Randhawa K; Jahani-Asl A
    Curr Top Membr; 2023; 92():99-123. PubMed ID: 38007271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of CLIC1 ion channel in glioblastoma-derived stem/progenitor cells.
    Setti M; Savalli N; Osti D; Richichi C; Angelini M; Brescia P; Fornasari L; Carro MS; Mazzanti M; Pelicci G
    J Natl Cancer Inst; 2013 Nov; 105(21):1644-55. PubMed ID: 24115360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G
    Peretti M; Raciti FM; Carlini V; Verduci I; Sertic S; Barozzi S; Garré M; Pattarozzi A; Daga A; Barbieri F; Costa A; Florio T; Mazzanti M
    Mol Cancer Ther; 2018 Nov; 17(11):2451-2461. PubMed ID: 30135216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.
    Miyazaki T; Pan Y; Joshi K; Purohit D; Hu B; Demir H; Mazumder S; Okabe S; Yamori T; Viapiano M; Shin-ya K; Seimiya H; Nakano I
    Clin Cancer Res; 2012 Mar; 18(5):1268-80. PubMed ID: 22230766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
    Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
    Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting A20 decreases glioma stem cell survival and tumor growth.
    Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
    PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
    Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
    Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
    Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
    Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
    Würth R; Pattarozzi A; Gatti M; Bajetto A; Corsaro A; Parodi A; Sirito R; Massollo M; Marini C; Zona G; Fenoglio D; Sambuceti G; Filaci G; Daga A; Barbieri F; Florio T
    Cell Cycle; 2013 Jan; 12(1):145-56. PubMed ID: 23255107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells.
    Tao W; Lei H; Luo W; Huang Z; Ling P; Guo M; Wan L; Zhai K; Huang Q; Wu Q; Xu S; Zeng L; Wang X; Dong Z; Rich JN; Bao S
    Neuro Oncol; 2023 Aug; 25(8):1428-1440. PubMed ID: 36521011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.